Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031957
Filing Date
2023-11-14
Accepted
2023-11-14 16:02:02
Documents
63
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pirs20230930_10q.htm   iXBRL 10-Q 1215835
2 EXHIBIT 10.1 ex_587528.htm EX-10.1 97409
3 EXHIBIT 10.2 ex_587530.htm EX-10.2 40777
4 EXHIBIT 10.3 ex_587529.htm EX-10.3 27677
5 EXHIBIT 31.1 ex_565356.htm EX-31.1 8558
6 EXHIBIT 31.2 ex_565357.htm EX-31.2 9283
7 EXHIBIT 32.1 ex_565358.htm EX-32.1 4250
8 EXHIBIT 32.2 ex_565359.htm EX-32.2 4231
  Complete submission text file 0001437749-23-031957.txt   5532222

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA pirs-20230930.xsd EX-101.SCH 49109
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pirs-20230930_cal.xml EX-101.CAL 36877
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20230930_def.xml EX-101.DEF 312893
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20230930_lab.xml EX-101.LAB 281335
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20230930_pre.xml EX-101.PRE 335283
57 EXTRACTED XBRL INSTANCE DOCUMENT pirs20230930_10q_htm.xml XML 774412
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37471 | Film No.: 231405684
SIC: 2834 Pharmaceutical Preparations